Related Experiment Video
Updated: Jun 26, 2026

11:24
Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
Published on: February 10, 2018
Hepatocyte transplantation in animal models
Anne Weber1, Marie-Thérèse Groyer-Picard, Dominique Franco
1Institut National de la Santé et de la Recherche Médicale Unité 804, Université Paris-Sud, Bicêtre Hospital, Kremlin-Bicêtre, France. anne.weber@inserm.fr
Summary
Hepatocyte transplantation shows promise for liver disease treatment, but challenges remain in cell engraftment and function. Recent advancements in animal models are improving outcomes for metabolic diseases and acute liver injury.
Area of Science:
- Hepatology
- Cell Therapy
- Regenerative Medicine
Background:
- Hepatocyte transplantation, using adult hepatocytes, is a key cell therapy for liver diseases.
- Despite over 30 years of research since the Gunn rat model for Crigler-Najjar syndrome, challenges in hepatocyte engraftment and function persist.
- Various animal models are crucial for advancing hepatocyte transplantation techniques.
Purpose of the Study:
- To review recent progress in enhancing hepatocyte transplantation for liver disease treatment.
- To highlight methods for improving in vitro hepatocyte amplification and in vivo engraftment and function.
- To focus on clinically applicable procedures for hepatocyte transplantation.
Main Methods:
- Exploration of adult hepatocytes as the primary cell source for liver cell therapy.
- Development of diverse approaches in animal models to improve hepatocyte transduction and amplification.
- Investigation of strategies to enhance in vivo cell engraftment and long-term functionality.
Main Results:
- Significant progress has been made in hepatocyte transplantation techniques across various animal models.
- Enhanced methods have improved hepatocyte engraftment and functionality in vivo.
- Successful applications include treating metabolic diseases and bridging patients with acute liver injury.
Conclusions:
- Adult hepatocytes remain the preferred cell source for liver disease cell therapy.
- Advancements in animal models are overcoming previous impediments to hepatocyte transplantation.
- The reviewed procedures show potential for clinical application in treating liver disorders.

